Effect of ionizing radiation on the stability and performance of the TAXUS Express2 paclitaxel-eluting stent

The advent of drug-eluting stents has provided the interventional cardiologist an effective new tool in treating coronary restenosis. There remains, however, a small group of patients that still require intervention following drug-eluting stent therapy. Currently, intravascular brachytherapy (IVBT)...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular radiation medicine 2004-07, Vol.5 (3), p.136-141
Main Authors: Dilcher, Christian, Chan, Rosanna, Hellinga, David, Seabron, Rufus, Pakala, Rajbabu, Kuchulakanti, Pramod K, Richard, Robert, Chan, Ken, Zhong, Samuel, Barry, James J, Waksman, Ron
Format: Article
Language:English
Subjects:
Analysis of Variance
Brachytherapy
Combined Modality Therapy
Coronary Restenosis - drug therapy
Coronary Restenosis - radiotherapy
Drug Carriers - radiation effects
Humans
In Vitro Techniques
Linear Models
Paclitaxel - administration & dosage
Polymers - radiation effects
Radiation, Ionizing
Stents
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The advent of drug-eluting stents has provided the interventional cardiologist an effective new tool in treating coronary restenosis. There remains, however, a small group of patients that still require intervention following drug-eluting stent therapy. Currently, intravascular brachytherapy (IVBT) is approved for use in the treatment of in-stent restenosis (ISR). This study investigated the effect of gamma and beta radiation doses typically used in IVBT on the performance of the TAXUS Express(2) paclitaxel-eluting stent. It was determined that there were no statistically significant changes to in vitro paclitaxel release from stent exposed to radiation compared to controls subjected to the same conditions except for the radiation exposure. The molecular weight of the Translute polymer carrier matrix and the level of paclitaxel degradants were not changed following exposure to radiation doses up to twice what is typically used in IVBT. Beta and gamma radiation doses typically used in IVBT had no significant effect on the Translute polymer carrier, paclitaxel degradation, or paclitaxel release in this in vitro model. The data are encouraging and support further evaluation of the use of IVBT in the treatment of ISR in the presence of drug-eluting stents.
ISSN:1522-1865
DOI:10.1016/j.carrad.2004.06.002